Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App




Sound Waves Separate Tumor and Blood Cells

By LabMedica International staff writers
Posted on 10 Sep 2014
A device has been developed that can test a cancer patient's blood for rare tumor cells and will be extremely useful for checking if a tumor is going to spread.

The relatively small device uses “tilted” sound waves, offering an effective way of sorting cells without having to treat them with chemicals or deform them mechanically. More...
These sound waves cross the cells' trajectory at an angle instead of going straight across, ensuring that each cell encounters several low-pressure nodes on its journey through the microchannel instead of just one.

Scientists at the Pennsylvania State University (University Park, PA, USA) working with colleagues from other institutes developed a unique configuration of tilted-angle standing surface acoustic waves (taSSAW),which are oriented at an optimally designed inclination to the flow direction in the microfluidic channel. To optimize the device design, they carried out systematic simulations of cell trajectories, matching closely with experimental results.

In their study, the team first tested their device using plastic beads and showed it could separate beads of 9.9 micrometers from beads of 7.3 micrometers in diameter with around 97% accuracy. The team also tested how well the device was able to separate a human breast cancer epithelial cell line Michigan Cancer Foundation-7 (MCF-7) that are 20 micrometers diameter from white blood cells that are about 12 micrometers in diameter. The cells also differ by compressibility and density. The results showed the cell sorter recovered around 71% of the cancer cells. One of the tests used to test cell viability and proliferation was the BrdU Cell Proliferation enzyme-linked immunosorbent assay (Roche Diagnostics, Indianapolis, IN, USA).

The team now plans to test the 18 mm device with blood samples from cancer patients in clinical settings. Circulating tumor cells are very rare as 1 mL of a typical cancer patient's blood may only contain a few tumor cells. The scientists have filed for a patent on their device. They see it helping clinicians determine whether a patient's tumor is about to spread to other sites of the body as tumors that are about to metastasize begin to send out cells that travel through the bloodstream.

The authors concluded that the simple design, low cost, and standard fabrication process of the device allows for easy integration with other laboratory-on-a-chip technologies and small radio frequency (RF) power supplies to further develop a fully integrated cell separation and analysis system. The study was published on August 25, 2014, in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS).

Related Links:

Pennsylvania State University 
Roche Diagnostics 



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.